作者: Alan Ashworth , Christopher James Lord , Sarah Martin
DOI:
关键词: Suppressor 、 Synthetic lethality 、 DNA mismatch repair 、 MSH6 、 Function (biology) 、 DNA polymerase 、 Biology 、 MSH2 、 Cancer research 、 Gene
摘要: Therapeutic approaches to the treatment of DNA mismatch repair (MMR) deficient cancers are disclosed based on use complimentary gene-function and drug screening synthetic lethality for designing therapies where loss tumour suppressor function has occurred. The work is experiments using human MSH2, an integral component MMR pathway, applicable other genes in particular MLHl, MSH6, PMSl PMS 2. In MSH2 synthetically lethal with inhibition polymerase POLbeta. Deficiency MLHl γ (POLG) inhibition.